New Approach to Educating Cancer Patients about Clinical Trials
Given that only a small percentage of adult cancer patients participate in clinical trials, UPMC Cancer Centers and a Pittsburgh-based health care technology company are launching an interactive Web site that will help patients and their families learn about clinical trials. The site simulates a conversation by allowing visitors to type in their own unique questions and receive video-based answers in real time from other cancer patients, medicalexperts and educational guides.
"Clinical trials are extremely important as more and more cancer drugs are developed that need to be tested," said Samuel Jacobs, M.D., associate director of clinical investigations at UPMC Cancer Centers. "Unfortunately, many cancer patients do not learn about participating in clinical trials or have fears and misconceptions about them. Our hope is that this site will allay those fears and provide helpful information by allowing patients to ask questions openly from the privacy of their own homes."
The site was developed by UPMC Cancer Centers along with MedRespond, a company founded to commercialize a Carnegie Mellon University-patented technology called the Synthetic Interview